| Oncolytics Biotech |
Calgary, AB |
Human Reovirus Delivery |
| OncoMyx Therapeutics |
Phoenix, AZ |
Oncolytic Immunotherapy |
| Gritstone Bio |
Emeryville, CA |
Personalized cancer vaccines |
| CG Oncology |
Irvine, CA |
Oncolytic Virus |
| Armata Pharmaceuticals |
Marina del Rey, CA |
Natural and synthetic bacteriophage-based therapies |
| Capsida Biotherapeutics |
Newbury Park, CA |
AAV Gene Therapy |
| PrimeVax Immuno-Oncology |
Orange, CA |
Dengue Virus combined with autologous dendritic cells |
| Adverum Biotechnologies |
Redwood City, CA |
Adeno-Associated Virus Delivery, Gene Therapy |
| DNAtrix |
San Diego, CA |
Oncolytic Virus |
| Oncolytics Biotech |
San Diego, CA |
Human Reovirus Delivery |
| Tenaya Therapeutics |
South SF, CA |
Cardiovascular Therapeutics |
| Shenogen Pharma |
Beijing, China |
Small Molecules, Biologics, Viral |
| Valo Therapeutics |
Helsinki, Finland |
Oncolytic Virus, Peptide |
| Transgene |
Illkirch-Graffenstaden, France |
Viral Vector Therapeutics, Gene Therapy |
| Transgene |
Lyon, France |
Viral Vector Therapeutics, Gene Therapy |
| Jaguar Gene Therapy |
Lake Forest, IL |
AAV-Based Gene Therapies |
| BioMarin Pharmaceutical |
Ringaskiddy County Cork, Ireland |
Biologics |
| Rigvir |
Riga, Latvia |
Oncolytic Virotherapy |
| Kelonia Therapeutics |
Boston, MA |
in vivo CAR T Gene Therapy |
| Transgene |
Boston, MA |
Viral Vector Therapeutics, Gene Therapy |
| Aura Biosciences |
Cambridge, MA |
Delivery by Pseudo-Viruses |
| Gritstone Bio |
Cambridge, MA |
Personalized cancer vaccines |
| Oncorus |
Cambridge, MA |
Oncolytic Virus Cancer Immunotherapy |
| Vedere Bio II |
Cambridge, MA |
Gene Therapy for Eyes |
| Voyager Therapeutics |
Cambridge, MA |
AAV capsid Gene Therapy |
| Replimune |
Woburn, MA |
Oncolytic immunotherapy |
| Lentigen |
Gaithersburg, MD |
Lentiviral Vector Technology & Services |
| Novavax |
Gaithersburg, MD |
Virus-like Particles, Micelles |
| AAVnerGene |
North Bethesda, MD |
Recombinant AAV for gene therapy, CDMO for AAV packaging |
| VectorY |
Amsterdam, Netherlands |
Vectorized Antibodies |
| Amarna Therapeutics |
Leiden, Netherlands |
Viral Gene Delivery Platform |
| Targovax |
Oslo, Norway |
Immuno-oncology |
| Apertura Gene Therapy |
New York, NY |
AAV vectors for Gene Therapy |
| Rocket Pharmaceuticals |
New York, NY |
Gene Therapies |
| Turnstone Biologics |
Ottawa, ON |
Oncolytic viral immunotherapy |
| Virica Biotech |
Ottawa, ON |
Viral Manufacturing Technology |
| Nuevocor |
Singapore , Singapore |
AAV-based Gene Therapy |
| VCN Biosciences |
Barcelona, Spain |
Oncolytic adenovirus technology platform |
| DiNAQOR |
Pfäffikon , Switzerland |
Gene Therapy for Heart Conditions |
| Redbiotec |
Schlieren, Switzerland |
Various Biologic Modalities |
| DNAtrix |
Houston, TX |
Oncolytic Virus |
| Replimune |
Abingdon, UK |
Oncolytic immunotherapy |
| DiNAQOR |
London, UK |
Gene Therapy for Heart Conditions |
| Theolytics |
Oxford, UK |
Oncolytic Adenovirus Therapies |
| Valo Therapeutics |
Oxford, UK |
Oncolytic Virus, Peptide |
| Icosavax |
Seattle, WA |
Vaccines, VLP |
| Capsigen |
Vancouver, WA |
AAV Vectors |
